H.C. Wainwright analyst Yi Chen reiterated a Hold rating on DENTSPLY SIRONA (NASDAQ:XRAY) Inc on Monday, setting a price target of $38, which is approximately 6.52% below the present share price of $40.65.
Chen expects DENTSPLY SIRONA Inc to post earnings per share (EPS) of $0.46 for the second quarter of 2020.
The current consensus among 9 TipRanks analysts is for a Moderate Buy rating of shares in DENTSPLY SIRONA, with an average price target of $49.33.
The analysts price targets range from a high of $66 to a low of $38.
In its latest earnings report, released on 12/31/2019, the company reported a quarterly revenue of $1.11 billion and a net profit of $149.2 million. The company's market cap is $8.9 billion.
According to TipRanks.com, H.C. Wainwright analyst Yi Chen is a 5-star analyst with an average return of 17.3% and a 44.8% success rate.
DENTSPLY SIRONA, Inc. engages in the design, manufacture, sales, and distribution of professional dental products and technologies. It operates through the Technologies and Equipment, and Consumables segments. The Technologies and Equipment segments comprises dental technology, equipment, and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers, and consumable medical device products. The Consumables segment offers preventive, restorative, instruments, endodontic, and orthodontic dental products. The company was founded in 2016 and is headquartered in York, PA.